KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

West Pharmaceutical Services (WST) Receivables - Net (2016 - 2026)

West Pharmaceutical Services has reported Receivables - Net over the past 18 years, most recently at $685.6 million for Q1 2026.

  • Quarterly Receivables - Net rose 26.12% to $685.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $685.6 million through Mar 2026, up 26.12% year-over-year, with the annual reading at $574.4 million for FY2025, 3.96% up from the prior year.
  • Receivables - Net was $685.6 million for Q1 2026 at West Pharmaceutical Services, up from $574.4 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $685.6 million in Q1 2026 and troughed at $479.4 million in Q2 2024.
  • The 5-year median for Receivables - Net is $524.3 million (2024), against an average of $540.6 million.
  • Biggest five-year swings in Receivables - Net: decreased 10.29% in 2024 and later grew 26.12% in 2026.
  • Tracing WST's Receivables - Net over 5 years: stood at $507.4 million in 2022, then grew by 0.91% to $512.0 million in 2023, then grew by 7.91% to $552.5 million in 2024, then rose by 3.96% to $574.4 million in 2025, then grew by 19.36% to $685.6 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $685.6 million, $574.4 million, and $625.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.